Zdrowie i gospodarka · 07/08/1995

Drug Export; NeupogenRegister Recombinant Methionyl Granulocyte Colony Stimulating Factor (r-metHuG-CSF) With Sorbitol

The Food and Drug Administration (FDA) is announcing that Amgen, Inc., has filed an application requesting approval for the export of the human biological product Neupogen Recombinant Methionyl Granulocyte Colony Stimulating Factor (r-metHuG-CSF) with sorbitol in vials, pre-filled syringes, and purified bulk, to Australia, Austria, Belgium, Canada, Denmark, Finland, France, Federal Republic of Germany, Iceland, Ireland, Italy, Japan, Luxembourg, the Netherlands, New Zealand, Norway, Portugal, Spain, Sweden, Switzerland, and the United Kingdom.